Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia

diarrhea and fatigue, but these are either mild or non-existent in doses that are known to induce tumor regression.

In Phase I/II trials, perifosine has induced tumor regressions and/or caused disease stabilization in a variety of tumor types. Perifosine has shown single agent partial responses or long term disease stabilizations in solid tumors including, renal, hepatocellular, sarcoma and prostate cancer. There is also evidence of activity in hematological malignancies, especially multiple myeloma. Responding patients, including those with stable disease, have been treated for months to more than three years.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals, Inc. is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Keryx's lead compound under development is Sulonex(TM) (sulodexide oral gelcap), previously referred to as KRX-101, a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a life-threatening kidney disease caused by diabetes. Sulonex is in a pivotal Phase III and Phase IV clinical program under a Special Protocol Assessment with the Food & Drug Administration. Additionally, Keryx is developing Zerenex(TM), an oral, inorganic, iron-based compound that has the capacity to bind phosphate and form non-absorbable complexes. Zerenex is currently in Phase II clinical development for the treatment of hyperphosphatemia (elevated serum phosphorous levels) in patients with end- stage renal disease. Keryx is also developing clinical-stage oncology compounds, including KRX-0401, a novel, first-in- class, oral modulator of Akt, a pathway associated with tumor survival and growth, and other important signal transduction pathways. KRX-0401 is currently in Phase II clinical development for multiple tumor types. Keryx also has an active in-licensing and acquisit
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
2. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:6/3/2015)... June 3, 2015  Flow cytometry remains an ... globe and keeping track of wide-ranging consumer needs ... In particular, ensuring user-friendliness, fluorescence capabilities, specialized research ... most important factors influencing end-user purchase decisions and ... New analysis from Frost & Sullivan, 2015 ...
(Date:6/3/2015)... , June 3, 2015  (AHIP Institute Booth ... information network, will be providing a wide range of ... future during the America,s Health Insurance Plan,s (AHIP,s) ... Tenn. Availity released a ... problem of waste and missed opportunities." The report ...
(Date:6/3/2015)... MALVERN, Pa. , June 3, 2015  Essential ... today that it has been invited to speak at ... New York city on June 4th.  ... Large Bore closure system, including a review of first ... systems.     MANTA closes femoral arterial punctures ...
Breaking Medicine Technology:Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 2Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 3Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 4Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 2Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 3Essential Medical Inc. Announces Participation in 2015 Jefferies Global Healthcare Conference - NYC 2
... ... ... ... , ...
... , ... ... ... ...
Cached Medicine Technology:Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone 2Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone 3Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone 4Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone 5Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 2Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 3Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 4Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 5Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 6Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 7Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 8Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 9Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 10Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 11Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 12Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 13Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 14Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 15Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 16Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 17Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 18Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 19Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 20
(Date:6/3/2015)... “ Harmony ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... improve some aspect of their life. , A common mistake ... with difficulties in their life. However, hypnotherapy is intended for ...
(Date:6/3/2015)... June 03, 2015 On June 22, 2015, ... of genetic drug sensitivity (pharmacogenetic) testing that it has reimbursed ... as many as 19 million of the 49 million Medicare ... costly and life-threatening adverse drug events.(1) Sadly, if it became ... , Precision Medicine, the use of an individual’s genetic information ...
(Date:6/3/2015)... York, NY (PRWEB) June 03, 2015 Dr. ... New York Cardiac Diagnostic Center ( http://www.newyorkcardiac.com ) located in ... appointments on weekdays to his practice. In most cases, depending ... time of the day they call, they will be seen ... “My first priority as a cardiologist is to ensure that ...
(Date:6/3/2015)... DC (PRWEB) June 03, 2015 Alberto ... Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire ... leadership, level of excellence, and commitment to service on ... the Global Connector Award that annually recognizes one DIA ... has advanced the mission of DIA to foster innovation ...
(Date:6/3/2015)... Justina Molzon, MS Pharm, JD will be ... Annual Meeting. DIA’s Global Inspire Award program recognizes the ... and commitment to service on a global scale. ... Award that recognizes the “Member of the Year” who ... who has contributed to the advancement of DIA’s mission. ...
Breaking Medicine News(10 mins):Health News:An Application to Enjoy Hypnotherapy Sessions at Home was featured on NewsWatch Television 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3
... groundbreaking Healthy Kids Program offers tools for family ... estimated at $14 billion annually- Employers and health ... of its kind personalized solution that provides tools ... and helps parents and kids become healthierMARIETTA, Ga., ...
... get on the map. , ... Washington, DC -- ... fundraiser challenge today to raise money to send lifesaving bed nets ... killer of refugees. Supporters are holding hundreds of fundraisers across the ...
... to Deliver eBill and Attachment Support for ... PECOS, N.M. and CONCORD, Calif., April 1 ... processing company serving the medical community, and ... integrated eBill and payment compliance services to ...
... to demonstrate HL7 interoperability for the Department of Defense,s MiCare System at ... ... 2009 -- iNTERFACEWARE is pleased to announce that its Iguana ... IHE demonstration of MiCare at the HIMSS Convention in Chicago next week. ...
... Más Pequeño del Mundo se ha introducido por MiCigarrillo™. El ... millones de fumadores en todo el mundo. , ... ... fumadores son adictos a la nicotina que se encuentra en ...
... talk about it with your doctor, but if childbirth ... pelvic organs, you need to know help is possible. ... Southeast Urogynecology at Women,s Specialty Center in Jackson, Miss. ... the entire southeast performing minimally invasive laparoscopic surgery at ...
Cached Medicine News:Health News:New Online Program Helps Parents Tackle Childhood Obesity 2Health News:New Online Program Helps Parents Tackle Childhood Obesity 3Health News:Nothing But Nets Launches World Malaria Day Fundraising Challenge 2Health News:Nothing But Nets Launches World Malaria Day Fundraising Challenge 3Health News:CLAIM.MD Adds Jopari Workers' Compensation Connectivity 2Health News:Iguana Selected for Department of Defense IHE Demonstration at HIMSS 09 2Health News:Iguana Selected for Department of Defense IHE Demonstration at HIMSS 09 3Health News:Cigarrillo Electronico "Excelente 2009" Introducido por MiCigarrillo™ 2Health News:Cigarrillo Electronico "Excelente 2009" Introducido por MiCigarrillo™ 3Health News:New Procedure To Correct Pelvic Prolapse Has Faster Recovery, Shorter Hospital Stay 2Health News:New Procedure To Correct Pelvic Prolapse Has Faster Recovery, Shorter Hospital Stay 3Health News:New Procedure To Correct Pelvic Prolapse Has Faster Recovery, Shorter Hospital Stay 4
... 3D Signature is a state of ... that integrates blood, sterile body fluid ... powerful microbiology workstation with comprehensive capabilities. ... identification and where expanded flexibility in ...
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid ANA II System, a microbial identification system....
IDS Rapid SS/u, a microbial identification system....
Medicine Products: